BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22752548)

  • 21. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T; Kitaura H; Masuda H; Kameyama S; Saito Y; Sugai K; Otsuki T; Nakazawa A; Morota N; Yamamoto T; Iida K; Nakagawa M; Mizuno T; Takahashi H; Kakita A
    Neuropathology; 2015 Oct; 35(5):401-9. PubMed ID: 25950494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
    Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
    Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
    Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
    Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
    Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
    Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
    J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
    Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
    Zurolo E; Iyer A; Maroso M; Carbonell C; Anink JJ; Ravizza T; Fluiter K; Spliet WG; van Rijen PC; Vezzani A; Aronica E
    Brain; 2011 Apr; 134(Pt 4):1015-32. PubMed ID: 21414994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell injury and premature neurodegeneration in focal malformations of cortical development.
    Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
    Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
    Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
    Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.
    Cepeda C; André VM; Hauptman JS; Yamazaki I; Huynh MN; Chang JW; Chen JY; Fisher RS; Vinters HV; Levine MS; Mathern GW
    Neurobiol Dis; 2012 Jan; 45(1):310-21. PubMed ID: 21889982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and cellular distribution of vascular endothelial growth factor-C system in cortical tubers of the tuberous sclerosis complex.
    Zhang CQ; Shu HF; Yin Q; An N; Xu SL; Yin JB; Song YC; Liu SY; Yang H
    Brain Pathol; 2012 Mar; 22(2):205-18. PubMed ID: 21767323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions.
    Prabowo AS; Iyer AM; Anink JJ; Spliet WG; van Rijen PC; Aronica E
    J Neuroinflammation; 2013 Jan; 10():12. PubMed ID: 23347564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
    Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
    Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
    Miyata H; Chiang AC; Vinters HV
    Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
    Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doublecortin expression in focal cortical dysplasia in epilepsy.
    Srikandarajah N; Martinian L; Sisodiya SM; Squier W; Blumcke I; Aronica E; Thom M
    Epilepsia; 2009 Dec; 50(12):2619-28. PubMed ID: 19583780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.